"Milrinone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase type 3 activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the inotropic potency of amrinone.
| Descriptor ID |
D020105
|
| MeSH Number(s) |
D02.092.080.085.543 D03.383.725.050.085.543
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Milrinone".
Below are MeSH descriptors whose meaning is more specific than "Milrinone".
This graph shows the total number of publications written about "Milrinone" by people in this website by year, and whether "Milrinone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Milrinone" by people in Profiles.
-
Use of milrinone to support therapy-induced heart failure through hematopoietic stem cell transplantation in a pediatric patient with high-risk FLT3+ acute myeloid leukemia. Pediatr Blood Cancer. 2023 10; 70(10):e30542.
-
A novel approach to diagnose reversible cerebral vasoconstriction syndrome: a case series. J Stroke Cerebrovasc Dis. 2015 Jan; 24(1):e31-7.
-
Loading conditions influence reliability of the echocardiographic ramp test in continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2013 Nov; 32(11):1142-4.
-
Letter by Rosner et al regarding article, "When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure". Circulation. 2013 Jan 29; 127(4):e431.
-
Suppressing apoptosis with milrinone simulating extracorporeal circulation: a pilot study. Thorac Cardiovasc Surg. 2010 Aug; 58(5):285-90.
-
Therapy for acute heart failure syndromes. Curr Cardiol Rep. 2009 May; 11(3):192-201.
-
Tirofiban (Aggrastat) protects platelets and decreases platelet-granulocyte binding in an extracorporeal circulation model. Thorac Cardiovasc Surg. 2006 Apr; 54(3):162-7.
-
Carvedilol titration in patients with congestive heart failure receiving inotropic therapy. Am Heart J. 2001 Sep; 142(3):512-5.
-
[The effect of milrinone administrated before weaning from cardiopulmonary bypass in adult cardiac surgery]. Kyobu Geka. 2000 Nov; 53(12):1019-23.
-
Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure. Am Heart J. 1996 Oct; 132(4):805-8.